Meiwan Chen
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 37
- Nanoparticle-Based Drug Delivery 28
-
- Curcumin's Biomedical Applications 10
Meiwan Chen
170 papers receiving 10.3k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Biomaterials 2.6k
- Pharmaceutical Science 751
- Molecular Medicine 501
- Biomedical Engineering 3.9k
- Pharmacology 755
Countries citing papers authored by Meiwan Chen
This map shows the geographic impact of Meiwan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiwan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiwan Chen more than expected).
Fields of papers citing papers by Meiwan Chen
This network shows the impact of papers produced by Meiwan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiwan Chen. The network helps show where Meiwan Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meiwan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 14 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 28 | |
| 6 | 2022 | 37 | |
| 7 | 2021 | 22 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 31 | |
| 10 | 2020 | 69 | |
| 11 | 2017 | 46 | |
| 12 | 2016 | 19 | |
| 13 | 2016 | 16 | |
| 14 | 2016 | 136 | |
| 15 | 2015 | 37 | |
| 16 | 2014 | 50 | |
| 17 | 2014 | 80 | |
| 18 | 2012 | 34 | |
| 19 | 2010 | 54 | |
| 20 | 2010 | 25 |
About Meiwan Chen
Meiwan Chen is a scholar working on Biomaterials, Molecular Medicine, Pharmaceutical Science, Pharmacology and Toxicology, having authored 171 papers that have together received 10.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (28 papers), RNA Interference and Gene Delivery (20 papers), Advanced biosensing and bioanalysis techniques (12 papers), Drug Transport and Resistance Mechanisms (11 papers), Curcumin's Biomedical Applications (10 papers), Pharmacological Effects of Natural Compounds (9 papers) and Ginseng Biological Effects and Applications (9 papers). The work is most often cited by research in Biomaterials (2.6k citations), Pharmaceutical Science (751 citations), Molecular Medicine (501 citations), Biomedical Engineering (3.9k citations) and Pharmacology (755 citations). Meiwan Chen has collaborated with scholars based in Macao, China and United States. Frequent co-authors include Yitao Wang, Zhuang Liu, Chengwei He, Jinming Zhang, Ziliang Dong, Yu Yang, Shengpeng Wang, Yitao Wang, Yu Chao and Liangzhu Feng. Their work appears in journals such as International Journal of Nanomedicine, The American Journal of Chinese Medicine, Journal of Controlled Release, International Journal of Pharmaceutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.